5/8/2019

1

Imaging in Neuro-ophthalmology (Clinician Concern)

Maher Assem, FRCS-Ed

Consultant Oculoplastic SurgeonEgypt

* How to read …?

* Neuro-ophthalmologyInterventional Radiology

* Orbit

5/8/2019

2

5/8/2019

3

• What Ophthalmologist should

know about Neuro- Imaging

• When to order CT

• When to order MRI

•Combined PET/CT

• The role of interventional

Neuroradiologists

5/8/2019

4

CT Scan

Differential Attenuation of X ray by tissues

- denser tissues attenuate more x rays -

5/8/2019

5

5/8/2019

6

MRI

Measurement of relaxation properties of

protons after excitation with

radiofrequency energy

5/8/2019

7

1 - CT or MRI

T2- WIT1- WI

5/8/2019

8

5/8/2019

9

Contrast

5/8/2019

10

Without contrast

Without contrast

5/8/2019

11

Without contrast

5/8/2019

12

Without contrast

5/8/2019

13

Without contrast

5/8/2019

14

Contrast

Contrast

5/8/2019

15

Contrast

4 - C.T. --- 1st Choice◼Orbital Trauma

◼F.B.

◼Ca -- TED ( decompression )

◼ Osseous – Cartilaginous – Fibro-osseous

lesions OR Suspicion of bony erosion

◼I.C. aneurysm clips

◼Cardiac Pacemakers –Defibrillators

◼Claustrophobia

5/8/2019

16

5 - MRI. --- 1st Choice

◼Acute proptosis

◼IO tumor with EO extension

◼Wood foreign body

◼ON Sheath complex lesion

◼Contraindications to CT

5/8/2019

17

Nomenclature

Bright Dark

CT scan Hyper-dense Hypo-dense

MRI Hyper-intense Hypo-intense

US Ecchogenic Eccholucent

Brain

5/8/2019

18

2 - Sections

Axial

5/8/2019

19

Coronal

Sagittal

5/8/2019

20

MRA

5/8/2019

21

Visual Field Defects with

important localizing Value

5/8/2019

22

Acromegaly

5/8/2019

23

Pituitary macro-adenoma > 1 cm

5/8/2019

24

Craniopharyngioma

5/8/2019

25

5/8/2019

26

Sphenoidal Ridge

meningioma

5/8/2019

27

Level /Visual Field Defects with important localizing Value

Without contrast

5/8/2019

28

Without Contrast

Intermittent Cranial Nerves

Affection

◼ MS

◼ Aneurysm

MRI (T2 WI)

MRA

5/8/2019

29

5/8/2019

30

5/8/2019

31

HYDROCEPHALUS

5/8/2019

32

Shunt

Periventricular Plaques ,,,, T2 WI ,,,, MS

5/8/2019

33

Arnold Chiari Malformation

Down Beat Nystagmus

5/8/2019

34

Down Beat Nystagmus

Convergence Retraction Nystagmus

5/8/2019

35

Posterior Fossa Lesions –

Hemangioblastoma Cerebellum

Upbeat Nystagmus

Nystagmus with Localizing Value

◼ See Saw Nyst. ( Chiasmal lesions, Parasellar lesions )

◼ Convergence Retraction Nystagmus ( Pinealomas )

◼ Down beat Nystagmus ( Cervico Medullary junction )

◼ Up beat Nystagmus ( Ponto-medullary junction,

post fossa lesions )

5/8/2019

36

◼ Morphologic & Metabolic Information in single

Examination

◼ PET tracers

* F-18-Fluro-2-deoxyglucose ( FDG )

Uptake in Tumours & Inflammation ( SUVmax )

Selective PET tracers

* Ga-68-DOTA-TATE ( agonist of SSTR

meningeomas – Neuroendocrine tumours )

* F-18-Fluoroethylcholine ( FEC ) CA. prostate mets.

Combined PET/CT

5/8/2019

37

Combined PET/CT

5/8/2019

38

Combined PET/CT

Combined PET/CT

5/8/2019

39

Ch Melanoma 1y after

Enucleation & silicon ball

implantation.

PET/CTCT

Interventional Radiology

5/8/2019

40

High Flow AVM

5/8/2019

41

5/8/2019

42

Cercoid Aneurysm

5/8/2019

43

5/8/2019

44

Mixed Flow ( AV Fistula )

5/8/2019

45

5/8/2019

46

Rt side Head trauma

Lt side CCF

Bilateral CCF

5/8/2019

47

Bilateral CCFCTA

Lt CCF with 6th n palsy

5/8/2019

48

ICA. Balloon

5/8/2019

49

2 Balloons

In Lt. ICA.

Before Balloon After Balloon

5/8/2019

50

Pre Post

Coil insertion

Poly Vinyl AcoholPoly Vinyl Acohol ( particles )

5/8/2019

51

5/8/2019

52

5/8/2019

53

1 wk. post-op 2 wks. post-op

4 ms. post-opPre-op

Conclusion

5/8/2019

54

THANK YOU

THANK YOU

Egypt